240 related articles for article (PubMed ID: 11526499)
1. Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells.
Sayan AE; Sayan BS; Findikli N; Ozturk M
Oncogene; 2001 Aug; 20(37):5111-7. PubMed ID: 11526499
[TBL] [Abstract][Full Text] [Related]
2. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
[TBL] [Abstract][Full Text] [Related]
3. Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
Cui R; Nguyen TT; Taube JH; Stratton SA; Feuerman MH; Barton MC
J Biol Chem; 2005 Nov; 280(47):39152-60. PubMed ID: 16203738
[TBL] [Abstract][Full Text] [Related]
4. Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
Pan H; Liao SJ; Lai WY; Lu HC; Hsiao KM
Acta Oncol; 2002; 41(6):550-5. PubMed ID: 12546528
[TBL] [Abstract][Full Text] [Related]
5. Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcript.
Pützer BM; Tuve S; Tannapfel A; Stiewe T
Cell Death Differ; 2003 May; 10(5):612-4. PubMed ID: 12728260
[No Abstract] [Full Text] [Related]
6. Transactivation-deficient DeltaTA-p73 acts as an oncogene.
Stiewe T; Zimmermann S; Frilling A; Esche H; Pützer BM
Cancer Res; 2002 Jul; 62(13):3598-602. PubMed ID: 12097259
[TBL] [Abstract][Full Text] [Related]
7. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.
Mihara M; Nimura Y; Ichimiya S; Sakiyama S; Kajikawa S; Adachi W; Amano J; Nakagawara A
Br J Cancer; 1999 Jan; 79(1):164-7. PubMed ID: 10408709
[TBL] [Abstract][Full Text] [Related]
8. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.
Stiewe T; Theseling CC; Pützer BM
J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800
[TBL] [Abstract][Full Text] [Related]
9. p73 is up-regulated in a subset of hepatocellular carcinomas.
Herath NI; Kew MC; Whitehall VL; Walsh MD; Jass JR; Khanna KK; Young J; Powell LW; Leggett BA; Macdonald GA
Hepatology; 2000 Mar; 31(3):601-5. PubMed ID: 10706549
[TBL] [Abstract][Full Text] [Related]
10. ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria.
Schuster A; Schilling T; De Laurenzi V; Koch AF; Seitz S; Staib F; Teufel A; Thorgeirsson SS; Galle P; Melino G; Stremmel W; Krammer PH; Müller M
Cell Cycle; 2010 Jul; 9(13):2629-39. PubMed ID: 20581467
[TBL] [Abstract][Full Text] [Related]
11. p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma.
Zemel R; Koren C; Bachmatove L; Avigad S; Kaganovsky E; Okon E; Ben-Ari Z; Grief F; Ben-Yehoyada M; Shaul Y; Tur-Kaspa R
Dig Dis Sci; 2002 Apr; 47(4):716-22. PubMed ID: 11991598
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73.
Stiewe T; Stanelle J; Theseling CC; Pollmeier B; Beitzinger M; Pützer BM
J Biol Chem; 2003 Apr; 278(16):14230-6. PubMed ID: 12584188
[TBL] [Abstract][Full Text] [Related]
13. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation.
Fontemaggi G; Gurtner A; Strano S; Higashi Y; Sacchi A; Piaggio G; Blandino G
Mol Cell Biol; 2001 Dec; 21(24):8461-70. PubMed ID: 11713281
[TBL] [Abstract][Full Text] [Related]
15. Relief of p53-mediated telomerase suppression by p73.
Toh WH; Kyo S; Sabapathy K
J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
[TBL] [Abstract][Full Text] [Related]
16. A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function.
Huqun ; Endo Y; Xin H; Takahashi M; Nukiwa T; Hagiwara K
Cancer Sci; 2003 Aug; 94(8):718-24. PubMed ID: 12901798
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
[TBL] [Abstract][Full Text] [Related]
18. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
19. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]